Methionine

Methionine

SCHEMBL2260610

CSCC[C@H](N)C(=O)O.N[C@@H](CO)C(=O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 10/20 0.50
BHMT2 Q9H2M3 1/20 0.50
RNPEP Q9H4A4 1/20 0.48
NOS2 P35228 3/20 0.46
NOS3 P29474 2/20 0.46
NOS1 P29475 2/20 0.46
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GSR P00390 1/20 0.43
CYP1A2 P05177 1/20 0.43
GRIK1 P39086 1/20 0.43
GRM5 P41594 1/20 0.43
GRIA1 P42261 1/20 0.43
GRIA2 P42262 1/20 0.43
GRIA3 P42263 1/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Racemethionine SCHEMBL2260603 1.00 BHMT (0.50) BHMTBHMT2RNPEPNOS2NOS3
Racemethionine SCHEMBL27691481 1.00 BHMT (0.50) BHMTBHMT2RNPEPNOS2NOS3
Racemethionine SCHEMBL27559551 0.94 BHMT (0.50) BHMTBHMT2RNPEPNOS2NOS3
Methionine SCHEMBL3883236 0.94 BHMT (0.50) BHMTBHMT2RNPEPNOS2NOS3
Methionine SCHEMBL3239125 0.94 BHMT (0.50) BHMTBHMT2RNPEPNOS2NOS3
Methionine SCHEMBL2022415 0.93 BHMT (0.46) BHMTBHMT2RNPEPNOS2NOS3
Racemethionine SCHEMBL23361954 0.92 BHMT (0.57) BHMTBHMT2RNPEPNOS2NOS3
Racemethionine SCHEMBL126688 0.92
Racemethionine SCHEMBL287590 0.92 BHMT (0.57) BHMTBHMT2RNPEPNOS2NOS3
Methionine SCHEMBL5584463 0.92 BHMT (0.57) BHMTBHMT2RNPEPNOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112920092-A Prodrugs of glutamine analogs 约翰霍普金斯大学 2021-06-08 CN disclosed
US-9090882-B2 Compositions and methods for enhanced amino acid levels in plants conferred by lysine and/or threonine feedback insensitive aspartate kinase proteins MONSANTO TECHNOLOGY LLC (US) 2015-07-28 US disclosed
EP-2729570-A2 REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS Qiagen GmbH (DE) 2014-05-14 EP disclosed
WO-2013004710-A2 REAGENT USABLE FOR THE ISOLATION AND/OR PURIFICATION OF NUCLEIC ACIDS QIAGEN GMBH (DE) 2013-01-10 WO disclosed
WO-2011113066-A1 METHODS AND SYSTEMS USING INTEGRATED METABOLOMICS AND PHARMACOKINETICS FOR MULTI-COMPONENT DRUG EVALUATION THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO (US) 2011-09-15 WO disclosed
US-20110191898-A1 Compositions and Methods for Enhanced Amino Acid Levels in Plants MONSANTO TECHNOLOGY LLC (US) 2011-08-04 US disclosed
WO-2010002876-A2 COMPOSITIONS AND METHODS FOR ENHANCED AMINO ACID LEVELS IN PLANTS MONSANTO TECHNOLOGY LLC (US) 2010-01-07 WO disclosed
EP-1572991-A4 COMPOSITIONS AND METHODS FOR HYDROXILATING EPOTHILONES BRISTOL MYERS SQUIBB CO (US) 2007-07-25 EP disclosed
EP-1465908-A4 COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES BRISTOL MYERS SQUIBB CO (US) 2005-11-30 EP disclosed
EP-1572991-A2 COMPOSITIONS AND METHODS FOR HYDROXILATING EPOTHILONES Bristol-Myers Squibb Company (US) 2005-09-14 EP disclosed
WO-2004061116-A2 COMPOSITIONS AND METHODS FOR HYDROXILATING EPOTHILONES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-07-22 WO disclosed
EP-0324789-B1 METHODS OF REGULATING METABOLIC STABILITY OF PROTEINS MASSACHUSETTS INST TECHNOLOGY (US) 2003-08-20 EP disclosed
WO-2003057830-A2 COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-17 WO disclosed
US-5847097-A Methods of generating desired amino-terminal residues in peptides MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1998-12-08 US disclosed
EP-0637247-B1 TREATMENT OF HERPESVIRUS INFECTION ALLELIX BIOPHARMA (CA) 1998-08-19 EP disclosed
US-5646017-A CONTROLLING METABOLIC STABILITY, DEGRADATION, PROTEOLYTIC CLEAVAGE OF FUSED PROTEINS TO UNMASK SPECIFIC AMINO-TERMINAL RESIDUE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1997-07-08 US disclosed
US-5496721-A PROTEINS AND CELLS FOR GENETICS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1996-03-05 US disclosed
US-5196321-A Gene expression; splitting with protease MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1993-03-23 US disclosed
US-5132213-A Peptide fusion for genetic engineering and protein synthesis MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1992-07-21 US disclosed
EP-0324789-A1 METHODS OF REGULATING METABOLIC STABILITY OF PROTEINS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-07-26 EP disclosed